Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells

Aravindan Narayanan1, Souvik Guha1,2, Avinash Mali1

  • 1BRIC-National Centre for Cell Science, Savitribai Phule Pune University, Pune, India.

Cell Death & Disease
|October 6, 2025
PubMed

Insights

Ovarian cancer stem-like cells utilize distinct protein networks for self-renewal, driven by mitochondrial activity and metabolic shifts, even without serum. Targeting mitochondria may offer a therapeutic strategy against tumor recurrence.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Ex vivo stem cell maintenance relies on serum-free conditions to avoid mitogens.
  • Ovarian cancer exhibits significant cellular and molecular heterogeneity, from epithelial to mesenchymal phenotypes.
  • Understanding stem-like cell behavior in this heterogeneous environment is crucial for effective treatment.

Purpose of the Study:

  • To investigate the proteomes of ovarian cancer stem-like cells across different phenotypes in serum-free media.
  • To identify common and distinct molecular pathways related to stemness and mitochondria.
  • To explore the metabolic adaptations and potential therapeutic targets in these cells.

Main Methods:

  • Proteomic analysis using MaxQuant-based label-free quantification.
  • Culturing high-grade serous ovarian cancer cell lines with varying phenotypes in serum-free media.
  • Assessing mitochondrial DNA, biogenesis, activity, and ultrastructure.
  • Investigating metabolic shifts from glycolysis to oxidative phosphorylation.

Main Results:

  • All ovarian cancer phenotypes in serum-free conditions showed activated mitochondria- and stemness-related pathways.
  • Specific proteins involved in these pathways were unique to each cell phenotype, indicating molecular heterogeneity.
  • Serum starvation induced increased mitochondrial DNA, biogenesis, and activity, shifting metabolism towards fatty acid oxidation.
  • Mitochondrial remodeling was implicated in regulating these metabolic fluctuations.

Conclusions:

  • Common cellular programs in ovarian cancer can be executed through diverse biological networks, leading to molecular heterogeneity.
  • Ovarian cancer stem-like cells adapt metabolically under serum starvation, enhancing mitochondrial function.
  • Targeting mitochondrial function presents a potential therapeutic strategy to limit tumor regenerative potential and recurrence.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K